Plain-English translation of NCT06712758 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a new cataract surgery machine called the Zeiss Quatera 700, designed to perform surgery while keeping pressure inside the eye much lower than traditional machines do. For people with glaucoma (a condition where high eye pressure damages the optic nerve), this lower-pressure approach may help protect the nerve during surgery and make the procedure safer overall.
People with glaucoma face extra risk during cataract surgery because their eyes are already sensitive to pressure changes. This new treatment aims to solve that problem by allowing surgeons to operate with pressure levels four times lower than standard machines, potentially preventing additional nerve damage.
You likely qualify if…
You likely don't qualify if…
You would undergo cataract surgery using the new Zeiss Quatera 700 machine at a participating eye clinic. The surgery itself is similar to standard cataract surgery, but performed with the innovative low-pressure technology. The study is observational, meaning doctors will monitor and record how well the new system works for glaucoma patients during and after their surgery.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Belgium
Started
November 2024
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Koen Willekens, Prof
Visionair Oogzorg
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.